Amag Pharmaceuticals Inc Asset Turnover Ratio (AMAG), as of third quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Amag Pharmaceuticals inc   (NASDAQ: AMAG)
 

Amag Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Amag Pharmaceuticals Inc asset turnover ratio, the ability of Amag Pharmaceuticals Inc 's assets to generate revenue in the third quarter 2020, increased sequentially to 0.41 in the third quarter (Sep 30 2020), yet the ratio remained below the average, as AMAG's position remain challenging.

Within sector 165 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2020 compared to the preceding quarter from 3142 to 3161.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMAG Asset Turnover Ratio (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Asset Change -24.03 % -30.14 % -29.76 % -32.67 % -20.5 %
Y / Y Revenue Change 10.67 % -32.46 % -9.42 % 1.8 % -31.17 %
Asset Turnover Ratio (TTM) 0.41 0.37 0.36 0.34 0.31
AMAG's Total Ranking # 3161 # 3142 # 2221 # 3138 # 3140
Seq. Asset Change 2.63 % -5.05 % -4.76 % -18.14 % -5.62 %
Seq. Revenue Change 76.49 % -23.17 % -23.46 % 6.63 % 7.71 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 166
Healthcare Sector # 450
Overall Market # 3161

Asset Turnover Ratio Statistics
High Average Low
11.04 6.28 3.43
(Dec 31 2013)   (Jun 30 2020)




AMAG Company Profile • Back to AMAG Efficiency Comparisons • Compare AMAG Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2020 Assets at quarter ending Sep 30 2020
Ewellness Healthcare Corporation  1.14 $ 0.267  Millions$ 0.235  Millions
Option Care Health Inc   1.12 $ 2,948.676  Millions$ 2,624.208  Millions
Nrc Health  1.11 $ 131.126  Millions$ 117.642  Millions
Perspective Therapeutics Inc   1.11 $ 9.749  Millions$ 8.777  Millions
Alimera Sciences Inc  1.10 $ 54.394  Millions$ 49.370  Millions
Mettler toledo International Inc   1.08 $ 2,991.160  Millions$ 2,780.321  Millions
Hca Healthcare Inc   1.07 $ 50,763.000  Millions$ 47,551.000  Millions
Regen Biopharma Inc   1.06 $ 0.110  Millions$ 0.103  Millions
Ernexa Therapeutics Inc   1.06 $ 9.793  Millions$ 9.246  Millions
Phibro Animal Health Corporation  1.05 $ 805.828  Millions$ 769.094  Millions
Diversicare Healthcare Services Inc   1.04 $ 457.573  Millions$ 437.924  Millions
Star Equity Holdings Inc   1.04 $ 91.160  Millions$ 87.400  Millions
Fulgent Genetics Inc   1.04 $ 135.121  Millions$ 130.327  Millions
Grapefruit Usa Inc   1.02 $ 2.700  Millions$ 2.657  Millions
Conformis inc   1.01 $ 71.953  Millions$ 70.894  Millions
Antares Pharma Inc   1.01 $ 143.305  Millions$ 142.063  Millions
Yunhong Green Cti Ltd   0.99 $ 25.850  Millions$ 26.093  Millions
Electromed Inc   0.99 $ 32.172  Millions$ 32.491  Millions
Adapthealth Corp   0.98 $ 857.501  Millions$ 874.024  Millions
Rockwell Medical inc   0.98 $ 62.523  Millions$ 63.741  Millions
Quidelortho Corp  0.98 $ 1,004.643  Millions$ 1,024.981  Millions
Vystar Corporation  0.98 $ 21.134  Millions$ 21.609  Millions
Inotiv Inc   0.98 $ 60.469  Millions$ 61.975  Millions
Neurometrix Inc   0.97 $ 7.275  Millions$ 7.511  Millions
Invacare Holdings Corporation  0.97 $ 859.559  Millions$ 887.788  Millions
Psychemedics Corporation  0.97 $ 24.740  Millions$ 25.624  Millions
Puma Biotechnology Inc   0.96 $ 235.475  Millions$ 246.486  Millions
Elite Pharmaceuticals Inc   0.95 $ 24.939  Millions$ 26.197  Millions
Ufp Technologies Inc   0.95 $ 184.480  Millions$ 195.214  Millions
Genmark Diagnostics Inc   0.94 $ 148.670  Millions$ 158.167  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.